| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Risks of Obesity Cited as #1 Health Issue in 2020 |
|
E-Articles - Risks of Obesity Cited as #1 Health Issue in 2020
Obesity” states U.S. National Institute of Health (NIH). Today, ninety-six million Americans are considered obese. But, what can be done to re According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product verse the trend? Try a low glycemic diet that is rich in whole grains and low in refined sugars ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in iods of time lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. those who get eight hours or more) here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e altered dramatically. There are factors that contribute to obesity. 1. Genetics 2. Environment< d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro blockquote>What are some of the negative impacts of obesity ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ?
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi fe of taking pills, or even worse, taking insulin shots. Diabetes leads to all sorts of other health complications, as well. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tack. People who are obese are at a significantly higher risk of having a heart attack. This fact is proven over and over again. Sudden cardia and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ c arrest is a fairly common cause of death for someone who is obese. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi of cancers. Yes, it is true. Although this connection wasn't clear for years, it is crystal clear now. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a eads to joint problems. Excess weight puts significant stress on each joint, even with the simplest of activities. Many obesity sufferers have dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod knee problems for this very reason. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ple who are diagnosed with this have a very difficult time breathing while they sleep. This makes them more tired during the day. A tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ecent study published by the Center for Disease Control (CDC) states that the combined direct and indirect health care costs resulting from ob t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ese and overweight Americans is estimated to be $117 billion per year. Statistics also demonstrate that death rates increase at least 200% for ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust people who are 50 pounds or more overweight.The National Institute of Health (NIH) has stated that an increase of 20% beyond ‘ideal body weig y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ht’ is the point at which excess weight becomes a health risk. There are many diseases which often follow obesity – such as high blood pressur . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e, high cholesterol, diabetes, sleep apnea, respiratory problems, bone and joint problems, coronary artery disease, stroke, some cancers, and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip many others. Each of these independently can have serious consequences to one’s health. The medical risks of diabetes are indeed profound. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Top 7 Tips for Buying New Construction Homes Do Your Homework and Stop Your Deals from Going Bad
|